Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Sandoz Doesn’t Need Biosimilars Purchases, Chief Tells Finanz

Novartis AG’s Sandoz unit doesn’t need acquisitions in the biosimilars business, Finanz und Wirtschaft reported, citing an interview with Jeff George, who heads the unit.

George said he expects a “shakeout” in the market as some smaller companies lack the technological abilities and commercial understanding needed to bring about sophisticated biosimilars, the newspaper reported.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.